{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:10:37Z","timestamp":1762377037899,"version":"3.40.5"},"reference-count":59,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"Intramural Research Program of the Center for Cancer Research, National Cancer Institute","award":["ZIA BC 009283"],"award-info":[{"award-number":["ZIA BC 009283"]}]},{"name":"Secretaria de Ciencia y Tecnolog\u00eda-UNC","award":["2018-2021"],"award-info":[{"award-number":["2018-2021"]}]},{"name":"Fundaci\u00f3n para el Progreso de la Medicina","award":["GC N\u00b01"],"award-info":[{"award-number":["GC N\u00b01"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.2217\/imt-2021-0080","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T11:32:33Z","timestamp":1637062353000},"page":"115-133","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic"],"prefix":"10.1080","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8614-3528","authenticated-orcid":false,"given":"Constanza","family":"Savid-Frontera","sequence":"first","affiliation":[{"name":"Inmunolog\u00eda, CIBICI-CONICET, Facultad de Ciencias Qu\u00edmicas, Universidad Nacional de C\u00f3rdoba, C\u00f3rdoba, 5000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5107-928X","authenticated-orcid":false,"given":"Maria E","family":"Viano","sequence":"additional","affiliation":[{"name":"Inmunolog\u00eda, CIBICI-CONICET, Facultad de Ciencias Qu\u00edmicas, Universidad Nacional de C\u00f3rdoba, C\u00f3rdoba, 5000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5178-228X","authenticated-orcid":false,"given":"Natalia S","family":"Baez","sequence":"additional","affiliation":[{"name":"Inmunolog\u00eda, CIBICI-CONICET, Facultad de Ciencias Qu\u00edmicas, Universidad Nacional de C\u00f3rdoba, C\u00f3rdoba, 5000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Della","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Cancer & Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD21702-1201USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Matellon","sequence":"additional","affiliation":[{"name":"Inmunolog\u00eda, CIBICI-CONICET, Facultad de Ciencias Qu\u00edmicas, Universidad Nacional de C\u00f3rdoba, C\u00f3rdoba, 5000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3118-5111","authenticated-orcid":false,"given":"Howard","family":"A\u00a0Young","sequence":"additional","affiliation":[{"name":"Cancer & Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD21702-1201USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5703-3116","authenticated-orcid":false,"given":"Maria C","family":"Rodriguez-Galan","sequence":"additional","affiliation":[{"name":"Inmunolog\u00eda, CIBICI-CONICET, Facultad de Ciencias Qu\u00edmicas, Universidad Nacional de C\u00f3rdoba, C\u00f3rdoba, 5000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1523-1"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.134"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600907"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903210"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804166"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033454261"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.6.3330"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090116"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-018-0310-5"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00335-8"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2009.159"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-5-66"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.6794"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4455"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.3.902.415k23_902_908"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0540"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00473-5"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007456"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242408"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.5.2796"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.12.7447"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(00)00354-9"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061363"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.05.026"},{"issue":"1","key":"e_1_3_5_26_1","first-page":"687","article-title":"Tumor angiogenesis and anti-angiogenic gene therapy for cancer","volume":"16","author":"Li T","year":"2018","unstructured":"Li T , KangG , WangT , HuangH. Tumor angiogenesis and anti-angiogenic gene therapy for cancer. Oncol. Lett.16(1), 687\u2013702 (2018).","journal-title":"Oncol. Lett."},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.11.5112"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01932.x"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1833166100"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1322"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.8.3.269"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-019-04851-2"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmy028"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021873"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2034"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2008.0845"},{"issue":"3","key":"e_1_3_5_37_1","first-page":"509","article-title":"Retroviral-mediated IL-12 gene transduction into human CD34+ cell-derived dendritic cells","volume":"21","author":"Akiyama Y","year":"2002","unstructured":"Akiyama Y , MaruyamaK , WatanabeM , YamaguchiK. Retroviral-mediated IL-12 gene transduction into human CD34+ cell-derived dendritic cells. Int. J. Oncol.21(3), 509\u2013514 (2002).","journal-title":"Int. J. Oncol."},{"issue":"1","key":"e_1_3_5_38_1","first-page":"9","article-title":"Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer","volume":"5","author":"Robertson MJ","year":"1999","unstructured":"Robertson MJ , CameronC , AtkinsMBet al. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. Clin. Cancer Res.5(1), 9\u201316 (1999).","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"e_1_3_5_39_1","first-page":"3383","article-title":"Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies","volume":"8","author":"Robertson MJ","year":"2002","unstructured":"Robertson MJ , PellosoD , AbonourRet al. Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies. Clin. Cancer Res.8(11), 3383\u20133393 (2002).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-020-0549-2"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0451-y"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/lam.12322"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1403"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2010.12"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201903462"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.11.027"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.08.001"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01385-8"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902371"},{"issue":"1","key":"e_1_3_5_50_1","first-page":"76","article-title":"Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses","volume":"9","author":"Portielje JE","year":"2003","unstructured":"Portielje JE , LamersCH , KruitWHet al. Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses. Clin. Cancer Res.9(1), 76\u201383 (2003).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.4.1465"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.156.8.2776"},{"issue":"3","key":"e_1_3_5_53_1","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins MB","year":"1997","unstructured":"Atkins MB , RobertsonMJ , GordonMet al. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin. Cancer Res.3(3), 409\u2013417 (1997).","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"e_1_3_5_54_1","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard JP","year":"1997","unstructured":"Leonard JP , ShermanML , FisherGLet al. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood90(7), 2541\u20132548 (1997).","journal-title":"Blood"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2018.06.022"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3150"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/genes9030136"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.137"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2015.023"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz768"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2021-0080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:52:31Z","timestamp":1715989951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2021-0080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.2217\/imt-2021-0080"],"URL":"https:\/\/doi.org\/10.2217\/imt-2021-0080","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"type":"print","value":"1750-743X"},{"type":"electronic","value":"1750-7448"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}